OPKO Health Inc. (OPK)
OPKO Health Statistics
Share Statistics
OPKO Health has 671.55M shares outstanding. The number of shares has increased by -2.08% in one year.
| Shares Outstanding | 671.55M |
| Shares Change (YoY) | -2.08% |
| Shares Change (QoQ) | -2.14% |
| Owned by Institutions (%) | 28.37% |
| Shares Floating | 303.35M |
| Failed to Deliver (FTD) Shares | 8.71K |
| FTD / Avg. Volume | 0.18% |
Short Selling Information
The latest short interest is 87.92M, so 12.88% of the outstanding shares have been sold short.
| Short Interest | 87.92M |
| Short % of Shares Out | 12.88% |
| Short % of Float | 28.49% |
| Short Ratio (days to cover) | 26.33 |
Valuation Ratios
The PE ratio is -19.17 and the forward PE ratio is -5.17. OPKO Health's PEG ratio is 0.28.
| PE Ratio | -19.17 |
| Forward PE | -5.17 |
| PS Ratio | 1.43 |
| Forward PS | 1.2 |
| PB Ratio | 0.75 |
| P/FCF Ratio | -4.89 |
| PEG Ratio | 0.28 |
Enterprise Valuation
OPKO Health Inc. has an Enterprise Value (EV) of 1.37B.
| EV / Earnings | -25.66 |
| EV / Sales | 1.92 |
| EV / EBITDA | 10.1 |
| EV / EBIT | -8.98 |
| EV / FCF | -6.55 |
Financial Position
The company has a current ratio of 3.43, with a Debt / Equity ratio of 0.39.
| Current Ratio | 3.43 |
| Quick Ratio | 3.13 |
| Debt / Equity | 0.39 |
| Total Debt / Capitalization | 27.91 |
| Cash Flow / Debt | -0.35 |
| Interest Coverage | -3.2 |
Financial Efficiency
Return on equity (ROE) is -0.04% and return on capital (ROIC) is -41.23%.
| Return on Equity (ROE) | -0.04% |
| Return on Assets (ROA) | -0.02% |
| Return on Capital (ROIC) | -41.23% |
| Revenue Per Employee | $237,951.95 |
| Profits Per Employee | $-17,759.09 |
| Employee Count | 2,997 |
| Asset Turnover | 0.32 |
| Inventory Turnover | 7.08 |
Taxes
| Income Tax | 42.84M |
| Effective Tax Rate | -4.13 |
Stock Price Statistics
The stock price has increased by 42.5% in the last 52 weeks. The beta is 1.71, so OPKO Health's price volatility has been higher than the market average.
| Beta | 1.71 |
| 52-Week Price Change | 42.5% |
| 50-Day Moving Average | 1.68 |
| 200-Day Moving Average | 1.53 |
| Relative Strength Index (RSI) | 44.12 |
| Average Volume (20 Days) | 4.78M |
Income Statement
In the last 12 months, OPKO Health had revenue of 713.14M and earned -53.22M in profits. Earnings per share was -0.08.
| Revenue | 713.14M |
| Gross Profit | 311.03M |
| Operating Income | -152.06M |
| Net Income | -53.22M |
| EBITDA | 135.28M |
| EBIT | -152.06M |
| Earnings Per Share (EPS) | -0.08 |
Balance Sheet
The company has 431.94M in cash and 528.54M in debt, giving a net cash position of -96.6M.
| Cash & Cash Equivalents | 431.94M |
| Total Debt | 528.54M |
| Net Cash | -96.6M |
| Retained Earnings | -2.07B |
| Total Assets | 2.2B |
| Working Capital | 468.99M |
Cash Flow
In the last 12 months, operating cash flow was -183.49M and capital expenditures -25.01M, giving a free cash flow of -208.5M.
| Operating Cash Flow | -183.49M |
| Capital Expenditures | -25.01M |
| Free Cash Flow | -208.5M |
| FCF Per Share | -0.3 |
Margins
Gross margin is 43.61%, with operating and profit margins of -21.32% and -7.46%.
| Gross Margin | 43.61% |
| Operating Margin | -21.32% |
| Pretax Margin | -1.45% |
| Profit Margin | -7.46% |
| EBITDA Margin | 18.97% |
| EBIT Margin | -21.32% |
| FCF Margin | -29.24% |
Dividends & Yields
OPK does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -4.68% |
| FCF Yield | -18.21% |
Analyst Forecast
The average price target for OPK is $3, which is 75.4% higher than the current price. The consensus rating is "Buy".
| Price Target | $3 |
| Price Target Difference | 75.4% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
Scores
| Altman Z-Score | 0.16 |
| Piotroski F-Score | 3 |